Bioequivalence of the pharmacokinetics between tofacitinib aspartate and tofacitinib citrate in healthy subjects

Tofacitinib is an oral disease-modifying anti-rheumatic drug to selectively inhibit Janus kinases. Tofacitinib is a representative small molecule inhibitor that is used to treat many diseases including rheumatoid arthritis and various autoimmune conditions. Unlike biological agents, tofacitinib has...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Wonsuk, Yang, A-Young, Yun, Hyeonji, Cho, Doo-Yeoun, Park, Kyung Hee, Shin, Hyunju, Kim, Anhye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533161/
https://www.ncbi.nlm.nih.gov/pubmed/33062629
http://dx.doi.org/10.12793/tcp.2020.28.e13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533161/
https://www.ncbi.nlm.nih.gov/pubmed/33062629
http://dx.doi.org/10.12793/tcp.2020.28.e13

Ejemplares similares